NeuroDex gets research grant from The Michael J. Fox Foundation to develop blood-based biomarker for Parkinson’s disease: Natick, Massachusetts Friday, November 15, 2024, 17:00 ...

Initiation of Phase 1b Study of GT-02287 in Parkinson’s patients expected by end of 2024BETHESDA, Md., Nov. 14, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage ...

New research highlights middle age as a pivotal period for brain health, with significant changes in how cells remove damaged mitochondria. Defects in this recycling process have been linked to ...

The program will match eligible contributions to almost 100 Minot-area organizations, from non-profits to healthcare ...

A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence ...

A deep learning AI model developed by researchers significantly accelerates the detection of pathology in animal and human ...

AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...

On Vancouver Island, privately owned forest poses a unique challenge for the Hul’qumi’num Treaty Group, with territories ...

Do you believe people become healthier when they listen to music? And when they sing? Or play an instrument? Or visit a ...

A new study by medicine safety experts found the use of gabapentinoids -- medicines widely used to treat neuropathic pain -- increased the risk of hip fractures, especially in older patients who were ...

Our Future Health, the UK's largest health research programme, will open appointments in 20 new locations next month, including in Runcorn.